MDT

85.6

-1.76%↓

118.07

-1.12%↓

VEEV

167.35

-0.11%↓

HQY

84.4

+0.63%↑

NEOG

9.24

-2.01%↓

MDT

85.6

-1.76%↓

118.07

-1.12%↓

VEEV

167.35

-0.11%↓

HQY

84.4

+0.63%↑

NEOG

9.24

-2.01%↓

MDT

85.6

-1.76%↓

118.07

-1.12%↓

VEEV

167.35

-0.11%↓

HQY

84.4

+0.63%↑

NEOG

9.24

-2.01%↓

MDT

85.6

-1.76%↓

118.07

-1.12%↓

VEEV

167.35

-0.11%↓

HQY

84.4

+0.63%↑

NEOG

9.24

-2.01%↓

MDT

85.6

-1.76%↓

118.07

-1.12%↓

VEEV

167.35

-0.11%↓

HQY

84.4

+0.63%↑

NEOG

9.24

-2.01%↓

Inicio・Lista de Acciones・Simulations Plus Inc

Simulations Plus Inc

Cerrado

SectorSanidad

14.07 -4.55

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

13.89

Máximo

14.82

Métricas clave
By Trading Economics
Ingresos	3.9M 4.5M
Ventas	5.9M 24M
BPA	0.35
Rentabilidad por dividendo	0.48
Margen de beneficios	18.669
Empleados	212
EBITDA	4.9M 7.2M

Recomendaciones
By TipRanks
Recomendaciones	Comprar
Estimación a 12 Meses	+60.52% upside

Dividendos
By Dow Jones
Rentabilidad por dividendo Media del Sector	0.48% 2.38%
Próximas Ganancias	13 jul 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	11M 262M
Apertura anterior	18.62
Cierre anterior	14.07

Noticias sobre sentimiento de mercado

By Acuity

50%

162 / 348 Clasificación en Healthcare

Simulations Plus Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

16 abr 2026, 23:26 UTC

Acciones populares

Stocks to Watch: Netflix, Alcoa, Knight-Swift, NiSource

16 abr 2026, 20:41 UTC

Principales Movimientos del Mercado

Netflix Shares Slide After 2Q Outlook Misses Wall Street's Expectations

16 abr 2026, 23:49 UTC

Charlas de Mercado

Amplitude's Pivot to Oil-Linked Supply Deal Catches Bull's Eye -- Market Talk

16 abr 2026, 23:45 UTC

Charlas de Mercado

Nikkei May Decline After Hitting Record High -- Market Talk

16 abr 2026, 23:33 UTC

Charlas de Mercado

Noticias de Eventos Importantes

Gold Edges Higher on Hopes for U.S.-Iran Deal -- Market Talk

16 abr 2026, 22:51 UTC

Charlas de Mercado

Netflix Sees Signs That Podcasts May Boost Engagement -- Market Talk

16 abr 2026, 22:08 UTC

Ganancias

Netflix Chair Reed Hastings to Leave Board in June -- 3rd Update

16 abr 2026, 22:06 UTC

Ganancias

Lundin Mining: Earnings From Discontinued Ops in 1Q Expected to Be Positively Impacted by Unaudited Gain on Disposal of Eagle Mine, Totaling Approximately $4M >LUN.T

16 abr 2026, 22:06 UTC

Ganancias

Lundin Mining: Pre-Announces Items Impacting 1Q Results

16 abr 2026, 22:06 UTC

Ganancias

Lundin Mining: Items of Significant Impact in 1Q Expected to Include Unaudited Realized Losses on Derivative Contracts of Approximately $13M, Primarily Related to Gold Collar Contracts >LUN.T

16 abr 2026, 22:06 UTC

Ganancias

Lundin Mining: Rev in 1Q Expected to Be Positively Impacted by Unaudited Provisional Pricing Adjustments on Prior-Period Concentrate Sales of Approximately $22M on Pre-Tax Basis >LUN.T

16 abr 2026, 22:06 UTC

Ganancias

Lundin Mining: Adjustments Primarily Include Upward Adjustments in Relation to Prior-Period Metal Sales >LUN.T

16 abr 2026, 20:50 UTC

Charlas de Mercado

Ganancias

Tech, Media & Telecom Roundup: Market Talk

16 abr 2026, 20:50 UTC

Charlas de Mercado

Financial Services Roundup: Market Talk

16 abr 2026, 20:50 UTC

Charlas de Mercado

Noticias de Eventos Importantes

Basic Materials Roundup: Market Talk

16 abr 2026, 20:50 UTC

Charlas de Mercado

Ganancias

Health Care Roundup: Market Talk

16 abr 2026, 20:49 UTC

Ganancias

SpaceX Is Ready to Go Public. The Stock Market Is Its Rocket. -- Barrons.com

16 abr 2026, 20:43 UTC

Ganancias

Update: Netflix Stock Falls on Weak Guidance. Founder Reed Hastings Is Leaving the Board. -- Barrons.com

16 abr 2026, 20:40 UTC

Charlas de Mercado

Ganancias

Global Equities Roundup: Market Talk

16 abr 2026, 20:40 UTC

Charlas de Mercado

Ganancias

Netflix Says Engagement Quality Hits New High -- Market Talk

16 abr 2026, 20:30 UTC

Acciones populares

Stocks to Watch: TSMC, Abbott Laboratories, Nvidia, Netflix -- WSJ

16 abr 2026, 20:25 UTC

Ganancias

Netflix Stock Falls on Weak Guidance. Founder Reed Hastings Is Leaving the Board. -- Barrons.com

16 abr 2026, 20:23 UTC

Ganancias

These Stocks Are Today's Movers: AMD, Intel, TSMC, Abbott, Hims, Corning, Schwab, Polaris, and More -- Barrons.com

16 abr 2026, 20:19 UTC

Ganancias

Netflix Guidance Disappoints. The Stock Is Down. -- Barrons.com

16 abr 2026, 20:17 UTC

Ganancias

Alcoa: Alumina Costs in the Aluminum Segment Are Expected to Be Favorable by Approximately $20M Sequentially >AA

16 abr 2026, 20:17 UTC

Ganancias

Alcoa: Based on Higher LME and Midwest Premium Pricing and Expected Higher Shipments, Section 232 Tariff Costs on U.S. Imports of Aluminum From Canada Expected to Increase $35M Sequentially >AA

16 abr 2026, 20:16 UTC

Ganancias

Alcoa: Expects 2026 Total Aluminum Segment Production and Shipments Ranging Between 2.4M and 2.6M Metric Tons, and Between 2.6M and 2.8M Metric Tons, Respectively >AA

16 abr 2026, 20:16 UTC

Ganancias

Alcoa: Expects 2026 Total Aluminum Segment Production and Shipments to Remain Unchanged From Its Prior Projection >AA

16 abr 2026, 20:16 UTC

Ganancias

Alcoa: Expects 2026 Total Alumina Segment Production and Shipments Ranging Between 9.7M to 9.9M Metric Tons, and Between 11.8M and 12.0M Metric Tons, Respectively >AA

16 abr 2026, 20:16 UTC

Ganancias

Alcoa: Expects 2026 Total Alumina Segment Production and Shipments to Remain Unchanged From Prior Projection >AA

Comparación entre iguales

Cambio de precio

Simulations Plus Inc previsión

Precio Objetivo

By TipRanks

60.52% repunte

Estimación a 12 Meses

Media 23.5 USD 60.52%

Máximo 31 USD

Mínimo 16 USD

De acuerdo con 4 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Simulations Plus Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

4 ratings

Comprar

Mantener

Vender

De acuerdo con 4 analistas que ofrecen calificaciones bursátiles a para Simulations Plus Inc Dist en los últimos 3 meses.

Sentimiento

By Acuity

162 / 348 Clasificación en Sanidad

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Simulations Plus Inc

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through Software and Services segments. It also offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. In addition, the company provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, and OBESITYsym products. Further, it offers Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as MonolixSuite products for modeling and simulation that allows for population analyses, rapid clinical trial data analyses, and regulatory submissions. Additionally, the company provides clinical-pharmacology-based consulting services, which includes population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions; and early drug discovery services. Furthermore, it offers creative and insightful consulting services to support its quantitative systems pharmacology and other modeling systems. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.